{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:53:15Z","timestamp":1790985195686,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013392","name":"Minist\u00e8re de la Sant\u00e9 et des Services sociaux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to describe community antibiotic use for respiratory and urinary tract infections (UTIs), in Quebec, from 2018 to 2022 and to assess the joint effect of comorbidities and the COVID-19 pandemic on prescription concordance with provincial guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted using medical and pharmaceutical claims data from 2018 to 2022 for individuals insured by the public health and drug plans. Data were sourced from the Quebec Integrated Chronic Disease Surveillance System (QICDSS), linking five administrative databases. The primary outcome was the proportion of prescriptions concordant with the provincial guidelines for the most frequent infections in children and adults. Prescriptions dispensed within two days of a medical diagnosis for eligible infections were included. Robust Poisson regressions assessed the joint impact of number of comorbidities and pandemic period on concordance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In children, over 90% of antibiotic prescriptions were concordant with guidelines. Lower concordance was observed for pneumonias and pharyngitis among children with comorbidities. In adults, concordance varied by infection type and declined with increasing comorbidities. Concordance improved during the pandemic and after for UTIs and rhinosinusitis, but decreased for pneumonias. No significant interactions were found between comorbidities and pandemic periods, except for bronchitis with chronic obstructive pulmonary disease (COPD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In Quebec, comorbidities were associated with decreased adherence to clinical guidelines for antibiotic prescribing, particularly among adults. The COVID-19 pandemic had minimal influence on concordance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13948-6","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:55:51Z","timestamp":1783511751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Joint impact of the number of comorbidities and the COVID-19 pandemic on the concordance of antibiotic prescriptions with clinical guidelines, in the community"],"prefix":"10.1186","volume":"26","author":[{"given":"Philip","family":"Verret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6612-9091","authenticated-orcid":false,"given":"\u00c9lise","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Magali-Ufitinema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Sauvageau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"13948_CR1","unstructured":"WHO\u2019s first global report on. antibiotic resistance reveals serious, worldwide threat to public health [Internet]. [cited 2023 Oct 3]. Available from: https:\/\/www.who.int\/southeastasia\/news\/detail\/30-04-2014-who-s-first-global-report-on-antibiotic-resistance-reveals-serious-worldwide-threat-to-public-health."},{"key":"13948_CR2","unstructured":"Canadian Antimicrobial Resistance Surveillance System (CARSS). Report 2022 [Internet]. 2022 [cited 2023 Aug 8]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/drugs-health-products\/canadian-antimicrobial-resistance-surveillance-system-report-2022.html."},{"key":"13948_CR3","unstructured":"Surveillance int\u00e9gr\u00e9e de la r\u00e9sistance aux antibiotiques | INSPQ [Internet]. Institut national de sant\u00e9 publique du Qu\u00e9bec. 2014 [cited 2023 Aug 8]. Available from: https:\/\/www.inspq.qc.ca\/publications\/1899."},{"issue":"10325","key":"13948_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet"},{"key":"13948_CR5","unstructured":"The biggest antibiotic-resistant threats in the U.S. [Internet]. Centers for disease control and prevention. 2022 [cited 2023 Aug 16]. Available from: https:\/\/www.cdc.gov\/drugresistance\/biggest-threats.html."},{"key":"13948_CR6","unstructured":"European Surveillance of Antimicrobial Consumption Network (ESAC-Net) [Internet]. 2015 [cited 2023 Oct 4]. Available from: https:\/\/www.ecdc.europa.eu\/en\/about-us\/partnerships-and-networks\/disease-and-laboratory-networks\/esac-net."},{"key":"13948_CR7","unstructured":"Gobernment of Canada. A propos de la sant\u00e9 publique du. Maladies et bact\u00e9ries r\u00e9sistantes aux antibiotiques [Internet]. 2014 [cited 2024 Nov 7]. Available from: https:\/\/www.canada.ca\/fr\/sante-publique\/services\/resistance-aux-antibiotiques-antimicrobiens\/maladies-et-bacteries-resistantes-aux-antibiotiques.html."},{"issue":"3","key":"13948_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","volume":"74","author":"J Davies","year":"2010","unstructured":"Davies J, Davies D. Origins and Evolution of Antibiotic Resistance. Microbiol Mol Biol Rev. 2010;74(3):417\u201333.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"3","key":"13948_CR9","doi-asserted-by":"publisher","first-page":"E831","DOI":"10.9778\/cmajo.20210258","volume":"10","author":"\u00c9 Fortin","year":"2022","unstructured":"Fortin \u00c9, Sirois C, Quach C, Jean S, Simard M, Dionne M, et al. Chronic diseases and variations in rates of antimicrobial use in the community: a population-based analysis of linked administrative data in Quebec, Canada, 2002\u20132017. CMAJ Open. 2022;10(3):E831\u201340.","journal-title":"CMAJ Open"},{"key":"13948_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejim.2015.11.021","volume":"28","author":"A Ticinesi","year":"2016","unstructured":"Ticinesi A, Nouvenne A, Folesani G, Prati B, Morelli I, Guida L, et al. An investigation of multimorbidity measures as risk factors for pneumonia in elderly frail patients admitted to hospital. Eur J Intern Med. 2016;28:102\u20136.","journal-title":"Eur J Intern Med"},{"key":"13948_CR11","unstructured":"Impact des maladies chroniques sur les taux d\u2019utilisation des antibiotiques dans la communaut\u00e9 | INSPQ [Internet]. Institut national de sant\u00e9 publique du Qu\u00e9bec. 2022 [cited 2023 Aug 10]. Available from: https:\/\/www.inspq.qc.ca\/publications\/2850."},{"issue":"4","key":"13948_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1089\/mdr.2016.0016","volume":"23","author":"A Laudisio","year":"2017","unstructured":"Laudisio A, Marinosci F, Gemma A, Bartoli IR, Montenegro N, Incalzi RA. The Burden of Comorbidity Is Associated with Antibiotic Resistance Among Institutionalized Elderly with Urinary Infection: A Retrospective Cohort Study in a Single Italian Nursing Home Between 2009 and 2014. Microb Drug Resist. 2017;23(4):500\u20136.","journal-title":"Microb Drug Resist"},{"key":"13948_CR13","unstructured":"Overview: COVID-19\u2019s impact on health care systems | CIHI [Internet]. [cited 2023 Aug 8]. Available from: https:\/\/www.cihi.ca\/en\/covid-19-resources\/impact-of-covid-19-on-canadas-health-care-systems\/the-big-picture."},{"issue":"11","key":"13948_CR14","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.3390\/healthcare10112293","volume":"10","author":"K Bouabida","year":"2022","unstructured":"Bouabida K, Lebouch\u00e9 B, Pomey MP. Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic. Healthcare. 2022;10(11):2293.","journal-title":"Healthcare"},{"issue":"3","key":"13948_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/bcp.15000","volume":"88","author":"MB Gillies","year":"2022","unstructured":"Gillies MB, Burgner DP, Ivancic L, Nassar N, Miller JE, Sullivan SG, et al. Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship. Br J Clin Pharmacol. 2022;88(3):1143\u201351.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"13948_CR16","doi-asserted-by":"publisher","first-page":"e096283","DOI":"10.1136\/bmjopen-2024-096283","volume":"15","author":"P Fortin","year":"2025","unstructured":"Fortin P, Fortin \u00c9, Sirois C, Quach C, Simard M, Magali-Ufitinema N, et al. The combined effect of the COVID-19 pandemic and the number of comorbidities on community antibiotic utilization rates: a population-based retrospective cohort study using linked health administrative data in Quebec, Canada. BMJ Open. 2025;15(8):e096283.","journal-title":"BMJ Open"},{"key":"13948_CR17","unstructured":"Global antimicrobial resistance and use surveillance. System (GLASS) [Internet]. [cited 2023 Aug 16]. Available from: https:\/\/www.who.int\/initiatives\/glass."},{"key":"13948_CR18","unstructured":"European antimicrobial resistance surveillance network (EARS-Net) [Internet]. 2017 [cited 2024 Nov 24]. Available from: https:\/\/www.ecdc.europa.eu\/en\/about-us\/networks\/disease-networks-and-laboratory-networks\/ears-net-data."},{"key":"13948_CR19","unstructured":"CDC. About the National Antimicrobial Resistance Monitoring System (NARMS). [Internet]. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS). 2024 [cited 2024 Nov 24]. Available from: https:\/\/www.cdc.gov\/narms\/about\/index.html."},{"key":"13948_CR20","unstructured":"La RAMQ en quelques chiffres | R\u00e9gie de l\u2019assurance maladie du Qu\u00e9bec (RAMQ) [Internet]. [cited 2023 Aug 16]. Available from: https:\/\/www.ramq.gouv.qc.ca\/fr\/donnees-statistiques\/ramq-quelques-chiffres."},{"key":"13948_CR21","unstructured":"Conna\u00eetre les conditions. d\u2019admissibilit\u00e9 \u00e0 l\u2019assurance maladie | R\u00e9gie de l\u2019assurance maladie du Qu\u00e9bec (RAMQ) [Internet]. [cited 2023 Oct 6]. Available from: https:\/\/www.ramq.gouv.qc.ca\/fr\/citoyens\/assurance-maladie\/connaitre-conditions-admissibilite."},{"key":"13948_CR22","unstructured":"Conna\u00eetre les conditions. d\u2019admissibilit\u00e9 au r\u00e9gime public d\u2019assurance m\u00e9dicaments | R\u00e9gie de l\u2019assurance maladie du Qu\u00e9bec (RAMQ) [Internet]. [cited 2023 Aug 16]. Available from: https:\/\/www.ramq.gouv.qc.ca\/fr\/citoyens\/assurance-medicaments\/connaitre-conditions-admissibilite-regime-public."},{"issue":"4","key":"13948_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.24095\/hpcdp.34.4.06","volume":"34","author":"C Blais","year":"2014","unstructured":"Blais C, Jean S, Sirois C, Rochette L, Plante C, Larocque I, et al. Quebec Integrated Chronic Disease Surveillance System (QICDSS), an innovative approach. Chronic Dis Inj Can. 2014;34(4):226\u201335.","journal-title":"Chronic Dis Inj Can"},{"key":"13948_CR24","unstructured":"Syst\u00e8me int\u00e9gr\u00e9 de surveillance des maladies chroniques du Qu\u00e9bec (SISMACQ) | INSPQ [Internet]. Institut national de sant\u00e9 publique du Qu\u00e9bec. [cited 2023 Oct 6]. Available from: https:\/\/www.inspq.qc.ca\/boite-outils-pour-la-surveillance-post-sinistre-des-impacts-sur-la-sante-mentale\/systemes-de-surveillance\/systeme-integre-de-surveillance-des-maladies-chroniques-du-quebec-sismacq."},{"key":"13948_CR25","unstructured":"Cadre de qualit\u00e9 des donn\u00e9es du. Syst\u00e8me int\u00e9gr\u00e9 de surveillance des maladies chroniques du Qu\u00e9bec | INSPQ [Internet]. Institut national de sant\u00e9 publique du Qu\u00e9bec. 2017 [cited 2023 Sep 12]. Available from: https:\/\/www.inspq.qc.ca\/publications\/2241."},{"key":"13948_CR26","unstructured":"INESSS [Internet]. INESSS. [cited 2023 Aug 8]. Available from: https:\/\/www.inesss.qc.ca\/en\/formations-et-outils\/outils-cliniques\/outils-par-types\/guides-dusage-optimal.html."},{"key":"13948_CR27","unstructured":"Anatomical Therapeutic Chemical (ATC). Classification [Internet]. [cited 2023 Aug 16]. Available from: https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification."},{"key":"13948_CR28","unstructured":"Humair JP, Kaiser L. Infections des voies respiratoires superieurs (IVRS). 2013."},{"issue":"5","key":"13948_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/MLR.0000000000000905","volume":"56","author":"M Simard","year":"2018","unstructured":"Simard M, Sirois C, Candas B. Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10. Med Care. 2018;56(5):441\u20137.","journal-title":"Med Care"},{"key":"13948_CR30","unstructured":"Blaser C, Hamel D, Sylvain-Morneau J, Gravel N, Gamache P, Azevedo Da Silva M. Indice de d\u00e9favorisation mat\u00e9rielle et sociale 2021. INSPQ. 2024 [cited 2026 May 19]. Available from: https:\/\/www.inspq.qc.ca\/publications\/3476."},{"key":"13948_CR31","unstructured":"Lefebvre F et al. Impact des maladies chroniques sur l\u2019adh\u00e9sion aux recommandations cliniques dans le traitement des infections urinaires. Dissertation. Universit\u00e9 Laval. 2021. Available at: http:\/\/hdl.handle.net\/20.500.11794\/69045."},{"issue":"3","key":"13948_CR32","doi-asserted-by":"publisher","first-page":"E841","DOI":"10.9778\/cmajo.20210257","volume":"10","author":"\u00c9 Fortin","year":"2022","unstructured":"Fortin \u00c9, Deceuninck G, Sirois C, Quach C, Simard M, Dionne M, et al. Chronic diseases and compliance with provincial guidelines for outpatient antibiotic prescription in cases of otitis media and respiratory infections: a population-based study of linked data in Quebec, Canada, 2010\u20132017. CMAJ Open. 2022;10(3):E841\u20137.","journal-title":"CMAJ Open"},{"issue":"11","key":"13948_CR33","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1093\/jac\/dkz345","volume":"74","author":"M Nowakowska","year":"2019","unstructured":"Nowakowska M, van Staa T, M\u00f6lter A, Ashcroft DM, Tsang JY, White A, et al. Antibiotic choice in UK general practice: rates and drivers of potentially inappropriate antibiotic prescribing. J Antimicrob Chemother. 2019;74(11):3371\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"13948_CR34","doi-asserted-by":"publisher","first-page":"e0292899","DOI":"10.1371\/journal.pone.0292899","volume":"18","author":"A Saatchi","year":"2023","unstructured":"Saatchi A, Reid JN, Shariff SZ, Povitz M, Silverman M, Patrick DM, et al. Retrospective cohort analysis of outpatient antibiotic prescribing for community-acquired pneumonia in Canadian older adults. PLoS ONE. 2023;18(10):e0292899.","journal-title":"PLoS ONE"},{"key":"13948_CR35","unstructured":"La pr\u00e9valence de la multimorbidit\u00e9 au Qu\u00e9bec.: portrait pour l\u2019ann\u00e9e 2016\u20132017 | INSPQ [Internet]. Institut national de sant\u00e9 publique du Qu\u00e9bec. 2019 [cited 2023 Oct 4]. Available from: https:\/\/www.inspq.qc.ca\/publications\/2577."},{"key":"13948_CR36","doi-asserted-by":"crossref","unstructured":"Taleb M, Abed AAK, Dahudi AR, Najim A, Ahmed A. Polypharmacy in primary care practices among chronic elderly patients in gaza strip. Pharmacol Pharm. 2014;5(3):291\u20137.","DOI":"10.4236\/pp.2014.53036"},{"key":"13948_CR37","unstructured":"Drug Interactions [Internet]. HSE.ie. [cited 2023 Aug 16]. Available from: https:\/\/www.hse.ie\/eng\/services\/list\/2\/gp\/antibiotic-prescribing\/drug-interactions\/drug-interactions-table.html."},{"issue":"1","key":"13948_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2165\/00003495-198020010-00004","volume":"20","author":"AJ Bint","year":"1980","unstructured":"Bint AJ, Burtt I. Adverse antibiotic drug interactions. Drugs. 1980;20(1):57\u201368.","journal-title":"Drugs"},{"issue":"1","key":"13948_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cmi.2014.09.011","volume":"21","author":"A Corsonello","year":"2015","unstructured":"Corsonello A, Abbatecola AM, Fusco S, Luciani F, Marino A, Catalano S, et al. The impact of drug interactions and polypharmacy on antimicrobial therapy in the elderly. Clin Microbiol Infect. 2015;21(1):20\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"13948_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/23744235.2020.1834139","volume":"53","author":"C Gagliotti","year":"2021","unstructured":"Gagliotti C, Buttazzi R, Ricchizzi E, Di Mario S, Tedeschi S, Moro ML. Community use of antibiotics during the COVID-19 lockdown. Infect Dis (Lond). 2021;53(2):142\u20134.","journal-title":"Infect Dis (Lond)"},{"key":"13948_CR41","unstructured":"Gouvernement du Canada SC. R\u00e9percussions de la COVID-19 sur les \u00e9tablissements de soins infirmiers et les r\u00e9sidences pour a\u00een\u00e9s au Canada en 2021 [Internet]. 2022 [cited 2023 Aug 16]. Available from: https:\/\/www150.statcan.gc.ca\/n1\/pub\/45-28-0001\/2022001\/article\/00011-fra.htm."},{"issue":"5","key":"13948_CR42","doi-asserted-by":"publisher","first-page":"e20182491","DOI":"10.1542\/peds.2018-2491","volume":"143","author":"KN Ray","year":"2019","unstructured":"Ray KN, Shi Z, Gidengil CA, Poon SJ, Uscher-Pines L, Mehrotra A. Antibiotic Prescribing During Pediatric Direct-to-Consumer Telemedicine Visits. Pediatrics. 2019;143(5):e20182491.","journal-title":"Pediatrics"},{"key":"13948_CR43","doi-asserted-by":"crossref","unstructured":"Martinez KA, Deshpande A, Stanley E, Rothberg MB. Antibiotic prescribing for respiratory tract infections in urgent care: a comparison of in-person and virtual settings. Clin Infect Dis. 2024;ciae396.","DOI":"10.1093\/cid\/ciae396"},{"issue":"1","key":"13948_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/tmj.2018.0250","volume":"26","author":"P Yao","year":"2020","unstructured":"Yao P, Clark S, Gogia K, Hafeez B, Hsu H, Greenwald P. Antibiotic Prescribing Practices: Is There a Difference Between Patients Seen by Telemedicine Versus Those Seen In-Person? Telemed J E Health. 2020;26(1):107\u20139.","journal-title":"Telemed J E Health"},{"issue":"6","key":"13948_CR45","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1111\/j.1475-6773.2008.00873.x","volume":"43","author":"G Cadieux","year":"2008","unstructured":"Cadieux G, Tamblyn R. Accuracy of physician billing claims for identifying acute respiratory infections in primary care. Health Serv Res. 2008;43(6):2223\u201338.","journal-title":"Health Serv Res"},{"issue":"8","key":"13948_CR46","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0895-4356(94)00234-H","volume":"48","author":"R Tamblyn","year":"1995","unstructured":"Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Qu\u00e9bec. J Clin Epidemiol. 1995;48(8):999\u20131009.","journal-title":"J Clin Epidemiol"},{"key":"13948_CR47","unstructured":"Utilisation. communautaire d\u2019antibiotiques \u2013 Projet de d\u00e9monstration \u00e0 partir des donn\u00e9es du Syst\u00e8me int\u00e9gr\u00e9 de surveillance sur les maladies chroniques du Qu\u00e9bec | INSPQ [Internet]. Institut national de sant\u00e9 publique du Qu\u00e9bec. 2019 [cited 2023 Oct 31]. Available from: https:\/\/www.inspq.qc.ca\/publications\/2511."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13948-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13948-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13948-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:02:15Z","timestamp":1790982135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13948-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13948"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13948-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the\n                      Comit\u00e9 d\u2019\u00e9thique de la recherche avec des \u00eatres humains de l\u2019Universit\u00e9 Laval.\n                      The use of QICDSS data by the INSPQ for surveillance purposes (including this project), has been approved by the\n                      Commission d\u2019acc\u00e8s \u00e0 l\u2019information du Qu\u00e9bec (CAI)\n                      , which granted a waiver of informed consent in accordance with Qu\u00e9bec regulations. Data were anonymized before we were given access to the database and no direct contact occurred with physicians or patients. The data was protected in accordance with security protocols established by the INSPQ.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1762"}}